Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750228 · ClinicalTrials.gov registry record
PDA Post NICU Discharge
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 208
- Enrollment target
NCT02750228: Completed study, sponsored by Pediatrix.
NCT02750228 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02750228 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants. The goal is to identify risk factors associated with adverse outcomes in prematurely born infants who are sent home with a PDA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-06-30 |
What the finished NCT02750228 record still lists
NCT02750228 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02750228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02750228 about?
NCT02750228 is a clinical study titled "PDA Post NICU Discharge". The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants....
What is the current status of trial NCT02750228?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2016-05. Estimated completion is 2020-06-30.
Who is sponsoring clinical trial NCT02750228?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia